Hemoglobin-based oxygen carriers: Disclosed history and the way ahead: The relativity of safety

Anesthesia and Analgesia

Volumn 119, Issue 4, 2014, Pages 758-760

  Weiskopf, Richard B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; NITRIC OXIDE; NITRIC OXIDE DONOR; OXYGEN; PLASMA SUBSTITUTE; UNCLASSIFIED DRUG; BLOOD SUBSTITUTE; POLYMERIZED HEMOGLOBIN;

AEROBIC METABOLISM; AMYLASE BLOOD LEVEL; BACTERIAL TRANSMISSION; DRUG SAFETY; EDITORIAL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FATALITY; GASTROINTESTINAL SYMPTOM; HEMODILUTION; HEMOGLOBIN DETERMINATION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERTENSION; IMMUNOMODULATION; INCIDENCE; KIDNEY INJURY; LUNG INJURY; MORTALITY; OXYGEN SUPPLY; PERIOPERATIVE PERIOD; PHASE 3 CLINICAL TRIAL (TOPIC); PRODUCT DEVELOPMENT; REPERFUSION INJURY; RISK FACTOR; SICKLE CELL ANEMIA; THROMBOCYTE TRANSFUSION; TORQUE TENO VIRUS; VIRUS TRANSMISSION; FEMALE; MALE; PROCEDURES;

BLOOD SUBSTITUTES; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; PERIOPERATIVE CARE;

EID: 84911384914     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000401     Document Type: Editorial

References (35)

1. Van Hemelrijck J, Levien LJ, Veeckman L, Pitman A, Zafrelis Z, Standl T. A safety and effcacy evaluation of hemoglobin-based oxygen carrier HBOC-201 in a randomized, multicenter red blood cell controlled trial in noncardiac surgery patients. Anesth Analg 2014;119:766-76
2. Weiskopf RB. Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials. Anesth Analg 2010;110:659-62
3. Silverman T, Landow L, Ko HS, Lindsey K: Review of publicly available reports of adverse events associated with HBOCs. Available at: http://www.fda.gov/downloads/biologics-bloodvaccines/newsevents/workshopsmeetingsconferences/ucm092845.pdf. Accessed December 27, 2013
4. Silverman TA, Weiskopf RB; Planning Committee and the Speakers. Hemoglobin-based oxygen carriers: current status and future directions. Anesthesiology 2009;111:946-63
5. Silverman TA, Weiskopf RB. Hemoglobin-based oxygen carriers: current status and future directions. Transfusion 2009;49:2495-515
6. Perkins HA, Busch M P. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010;50:2080-99
7. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J. Serum alanine aminotrans-ferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981;304:989-94
8. Ammann AJ, Cowan MJ, Wara DW, Weintrub P, Dritz S, Goldman H, Perkins HA. Acquired immunodefciency in an infant: possible transmission by means of blood products. Lancet 1983;1:956-8
9. Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, Weinstein R, Lui KJ, Schonberger LB, Spira TJ, Alexander J, Swinger G, Ammann A, Solomon S, Auerbach D, Mildvan D, Stoneburner R, Jason J, Haverkos H, Evatt BL. Acquired immunodefciency syndrome (AIDS) associated with transfusions. N Engl J Med 1984;310:69-75
10. Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA. Risk of human immunodefciency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion 1991;31:4-11
11. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH; NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64
12. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL. Prevalence, incidence, and residual risk of human immunodefciency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-504
13. Epstein JS, Jaffe HW, Alter HJ, Klein HG. Blood system changes since recognition of transfusion-associated AIDS. Transfusion 2013;53:2365-74
14. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757-67
15. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013;53:1442-9
16. U.S. FDA. Fatalities reported to FDA following blood collection and transfusion: Annual summary for fscal year 2012. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639. htm. Accessed January 25, 2014
17. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, Hickner A, Rogers MA. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analy-sis. JAMA 2014;311:1317-26
18. Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational "before-and-after" studies. Vox Sang 2004;86:111-9
19. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999;91:861-5
20. Weiskopf RB. The effcacy and safety of liquid stored blood and storage duration: a confused subject; are patients confused? Anesth Analg 2014;119:224-9
21. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-39
22. Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010;50:1185-95
23. Fergusson DA, Hébert P, Hogan DL, LeBel L, Rouvinez-Bouali N, Smyth JA, Sankaran K, Tinmouth A, Blajchman MA, Kovacs L, Lachance C, Lee S, Walker CR, Hutton B, Ducharme R, Balchin K, Ramsay T, Ford JC, Kakadekar A, Ramesh K, Shapiro S. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012;308:1443-51
24. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ Jr, Gomez GA, Cipolle MD, Rodman GH Jr, Malangoni MA, Hides GA, Omert LA, Gould SA; PolyHeme Study Group. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009;208:1-13
25. Viele M, Weiskopf R, Fisher D. Renal effects and pharmaco-kinetics of recombinant human hemoglobin. Anesthesiology 1997;86:848-58
26. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 2004;3:152-9
27. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 1999;17:545-9
28. Winslow RM. Oxygen: the poison is in the dose. Transfusion 2013;53:424-37
29. Winslow RM. Cell-free oxygen carriers: scientifc foundations, clinical development, and new directions. Biochim Biophys Acta 2008;1784:1382-6
30. Santayana G. Reason in Common Sense, The Life of Reason. Volume 1. New York, Charles Scribner's Sons, 1905, pp 284
31. Weiskopf RB, Silverman TA. Balancing potential risks and benefts of hemoglobin-based oxygen carriers. Transfusion 2013;53:2327-33
32. Emanuel E; Center for Biologics Evaluation and Research, FDA; The National Heart, Lung, and Blood Institute, NIH; and Offce of the Secretary and Offce of Public Health and Science, DHHS. Hemoglobin based oxygen carriers: current status and future directions. Bethesda, MD, 2008, pp 249-59. April 30, 2008. Available at: www.fda.gov/downloads/biologics-bloodvaccines/newsevents/workshopsmeetingsconferences/ucm133812.pdf. Accessed January 14, 2014
33. Milton J. Areopagitica. London, 1644
34. Jefferson T. First Inaugural Address. March 4, 1801
35. Phillips J. Look through my window. American Broadcasting Music Inc., c. 1964